These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5142666)

  • 1. The prolonged release of caramiphen hydrochloride and atropine sulfate from compressed tablets containing carbopol 934.
    Baun DC; Walker GC
    Pharm Acta Helv; 1971 Feb; 46(2):94-113. PubMed ID: 5142666
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycerin ester of higher fatty acids as pharmaceutic aids. 6. Release of an imbedded drug from tablets containing higher fatty acids and their esters].
    Chalabala M; Starha L
    Pharmazie; 1970 Sep; 25(9):535-8. PubMed ID: 5486680
    [No Abstract]   [Full Text] [Related]  

  • 3. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Release of a solid, easily soluble compound from the hydrophobic tablet matrix influenced by surface-active agents].
    Schekerdschijski R; Minkov E; Guschev A; Trandafilov T
    Pharmazie; 1973 Jul; 28(7):450-2. PubMed ID: 4767492
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preparation of carbopol gels containing benzoylperoxide (author's transl)].
    Remon JP; Van Severen R; Braeckman P
    J Pharm Belg; 1979; 34(2):99-100. PubMed ID: 512825
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug content uniformity of directly compressed tablets in relation to the physical characteristics of diluents.
    Colombo P; Conte U; Caramella C; La Manna A; Catellani PL
    Boll Chim Farm; 1978 Dec; 117(12):711-20. PubMed ID: 752353
    [No Abstract]   [Full Text] [Related]  

  • 7. [Injection casting procedure for the preparation of oral delayed-action preparations. 4. Break-in of channeling pharmaceutic aids].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1976 Jul; 31(7):471-4. PubMed ID: 981302
    [No Abstract]   [Full Text] [Related]  

  • 8. Fast dispersible/slow releasing ibuprofen tablets.
    Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
    Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the drug forms with prolonged action].
    Bogs U
    Pharm Prax; 1966; 10():217-22. PubMed ID: 6001091
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of some factors affecting the in-vitro release of drug from prolonged release granulations. 1. Effect of method of preparation.
    Asker AF; Motawi AM; Abdel-Khalek MM
    Pharmazie; 1971 Mar; 26(3):170-2. PubMed ID: 5574493
    [No Abstract]   [Full Text] [Related]  

  • 11. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M; Peppas NA; McGinity JW
    J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
    Ozeki Y; Ando M; Watanabe Y; Danjo K
    J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of drug release from coated parenteral matrix-retard tablets using softening agents].
    Korsatko W; Wabnegg B
    Pharmazie; 1983 Sep; 38(9):608-11. PubMed ID: 6647533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compressed collagen sponges as gastroretentive dosage forms: in vitro and in vivo studies.
    Gröning R; Cloer C; Georgarakis M; Müller RS
    Eur J Pharm Sci; 2007 Jan; 30(1):1-6. PubMed ID: 17101267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tablets. XVII. Effect of pressure on the liberation in vitro of sodium salicylate from prolonged-action tablets].
    Terrier JL; Cruaud-Mangenot O; Duchène D; Puisieux F
    Pharm Acta Helv; 1976; 51(5):144-52. PubMed ID: 967910
    [No Abstract]   [Full Text] [Related]  

  • 18. [Advances in the production and control of tablets. XVIII. Modified starches as pharmaceutic aids].
    Chalabala M; Heliová M
    Cesk Farm; 1977 Apr; 26(3):108-11. PubMed ID: 872228
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hydrophilic gel matrix tablets for oral administration of drugs].
    Rabisková M; Vostalová L; Medvecká G; Horácková D
    Ceska Slov Farm; 2003 Sep; 52(5):211-7. PubMed ID: 14619697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Formulation of sustained release tablets. I. Inert matrices].
    Salomen JL; Doelker E
    Pharm Acta Helv; 1980; 55(7):174-82. PubMed ID: 7413682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.